KN019
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for KN019, covering 2023-03-01 to 2023-03-01. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety Study of KN019 in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate [Phase 2]